A Biomimetic Nanocarrier Strategy Targets Ferroptosis and Efferocytosis During Myocardial Infarction
International Journal of Nanomedicine · 2024-08 · Volume 19 · 8253-8270
DOI: 10.2147/ijn.s461212 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024-08. Verfasst von Lin Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Qingdao University, Qingdao, 266071, People's Republic of China. Hauptthemen laut MEDLINE: Myocardial Infarction, Ferroptosis, Myocytes, Cardiac, Nanoparticles. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Qingdao University, Qingdao, 266071, People's Republic of China.
Zitieren
APA
Song, L., Yuan, X., Zhao, Z., Wang, P., Wu, W., & Wang, J. (2024). A Biomimetic Nanocarrier Strategy Targets Ferroptosis and Efferocytosis During Myocardial Infarction. International Journal of Nanomedicine, Volume 19, 8253-8270. https://doi.org/10.2147/ijn.s461212
Vancouver
Song L, Yuan X, Zhao Z, Wang P, Wu W, Wang J. A Biomimetic Nanocarrier Strategy Targets Ferroptosis and Efferocytosis During Myocardial Infarction. International Journal of Nanomedicine. 2024;Volume 19:8253-8270. doi:10.2147/ijn.s461212
BibTeX
@article{Song2024,
author = {Song, Lin and Yuan, Xiaosu and Zhao, Zhonghao and Wang, Peiyan and Wu, Weiwei and Wang, Jianxun},
title = {A Biomimetic Nanocarrier Strategy Targets Ferroptosis and Efferocytosis During Myocardial Infarction},
journal = {International Journal of Nanomedicine},
year = {2024},
volume = {Volume 19},
pages = {8253--8270},
doi = {10.2147/ijn.s461212}
}
EUVIMED